Carregant...
PET neuroimaging studies of [(18)F]CABS13 in a double transgenic mouse model of Alzheimer’s disease and non-human primates
Fluorine-18 labeled 2-fluoro-8-hydroxyquinoline ([(18)F]CABS13) is a promising positron emission tomography (PET) radiopharmaceutical based on a metal chelator developed to probe the “metal hypothesis of Alzheimer’s disease”. Herein, a practical radiosynthesis of [(18)F]CABS13 was achieved by radiof...
Guardat en:
| Publicat a: | ACS Chem Neurosci |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4879824/ https://ncbi.nlm.nih.gov/pubmed/25776827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.5b00055 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|